Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Anthera Pharmaceuticals Inc | 1,847,074 | reported | 05 Jan 2018 | tx 10+2,734,864 |
| Esperion Therapeutics, Inc. | 79,873 | reported | 28 May 2026 | tx 2+119,873 |
| TETRAPHASE PHARMACEUTICALS INC | 343 | reported | 08 Sept 2015 | tx 21+442,499−184,998 |
| Trius Therapeutics Inc | 0 | reported | 11 Sept 2013 | tx 8+365,133−367,455 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | GRANT_AWARD | Esperion Therapeutics, Inc. | 79,873 | 0.00 USD | |
| 01 Jul 2025 | GRANT_AWARD | Esperion Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 05 Jan 2018 | GRANT_AWARD | Anthera Pharmaceuticals Inc | 1,847,074 | 0.00 USD | deriv |
| 20 Sept 2017 | PURCHASE | Anthera Pharmaceuticals Inc | 8,550 | 1.32 USD | |
| 07 Sept 2017 | EXERCISE | Anthera Pharmaceuticals Inc | 10,400 | 1.43 USD | |
| 20 May 2017 | GRANT_AWARD | Anthera Pharmaceuticals Inc | 81,250 | 0.00 USD | deriv |
| 03 Mar 2017 | GRANT_AWARD | Anthera Pharmaceuticals Inc | 100,000 | 0.00 USD | deriv |
| 11 Jan 2017 | GRANT_AWARD | Anthera Pharmaceuticals Inc | 7,190 | 0.55 USD | |
| 06 Dec 2016 | GRANT_AWARD | Anthera Pharmaceuticals Inc | 300,000 | 0.00 USD | deriv |
| 09 Jun 2016 | GRANT_AWARD | Anthera Pharmaceuticals Inc | 170,000 | 0.00 USD | deriv |
| 08 Sept 2015 | SALE | TETRAPHASE PHARMACEUTICALS INC | 10,000 | 44.08 USD | |
| 08 Sept 2015 | EXERCISE | TETRAPHASE PHARMACEUTICALS INC | 10,000 | 14.45 USD | |
| 08 Sept 2015 | EXERCISE | TETRAPHASE PHARMACEUTICALS INC | 10,000 | 0.00 USD | deriv |
| 05 Aug 2015 | SALE | TETRAPHASE PHARMACEUTICALS INC | 10,000 | 46.31 USD | |
| 05 Aug 2015 | EXERCISE | TETRAPHASE PHARMACEUTICALS INC | 10,000 | 14.45 USD | |
| 05 Aug 2015 | EXERCISE | TETRAPHASE PHARMACEUTICALS INC | 10,000 | 0.00 USD | deriv |
| 06 Jul 2015 | SALE | TETRAPHASE PHARMACEUTICALS INC | 10,000 | 47.91 USD | |
| 06 Jul 2015 | EXERCISE | TETRAPHASE PHARMACEUTICALS INC | 10,000 | 14.45 USD | |
| 06 Jul 2015 | EXERCISE | TETRAPHASE PHARMACEUTICALS INC | 10,000 | 0.00 USD | deriv |
| 15 Jun 2015 | SALE | TETRAPHASE PHARMACEUTICALS INC | 10,000 | 41.51 USD | |
| 15 Jun 2015 | EXERCISE | TETRAPHASE PHARMACEUTICALS INC | 10,000 | 14.45 USD | |
| 15 Jun 2015 | EXERCISE | TETRAPHASE PHARMACEUTICALS INC | 10,000 | 0.00 USD | deriv |
| 08 Jun 2015 | EXERCISE | TETRAPHASE PHARMACEUTICALS INC | 22,499 | 14.45 USD | |
| 08 Jun 2015 | SALE | TETRAPHASE PHARMACEUTICALS INC | 10,637 | 43.00 USD | |
| 08 Jun 2015 | SALE | TETRAPHASE PHARMACEUTICALS INC | 11,862 | 43.50 USD |